Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 917.35 INR
Change Today -11.30 / -1.22%
Volume 64.9K
As of 4:25 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter De Young

Chief Executive Officer of Critical Care, Piramal Enterprises Limited
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 2 different industries.

See Board Relationships
--25,200,000
As of Fiscal Year 2015

Background*

Mr. Peter De Young serves as Chief Executive Officer of Critical Care at Piramal Enterprises Limited. Mr. De Young serves as a Director of Ascendancy Healthcare, Inc. He served as the President of NCE at Piramal Enterprises Limited. Mr. De Young is jointly responsible for the NCE Research division of Piramal Enterprises, Piramal Life Sciences. His specific responsibilities in the NCE Research division include business development, strategy, finance, project management ...

Read Full Background

Corporate Headquarters*

247 Business Park
Mumbai, Maharashtra 400083

India

Phone: 91 22 3095 66666
Fax: --

Board Members Memberships*

Director

Education*

MBA
Stanford University
BS
Princeton University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Calculated Compensation25,200,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIEL:IN 917.35 INR -11.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
$550.0K
Samir Uttamlal Mehta B.Com., MBAExecutive Chairman, Managing Director, Member of Securities Transfer & Stakeholders Relationship Committee and Member of Committee of Directors
Torrent Pharmaceuticals Ltd.
--
Hari Shankar Bhartia B.TechCo-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Compensation Committee, Member of Fund Raising Committee, Member of Finance Committee and Member of Sustainability & CSR Committee
Jubilant Life Sciences Limited
--
Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.)Chief Executive Officer, Joint Managing Director and Executive Director
Biocon Limited
25.5M
Murali Krishna Prasad Divi M. Pharm, Ph.D.Chairman, Managing Director and Member of Corporate Social Responsibility Committee
Divi's Laboratories Limited
9.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIRAMAL ENTERPRISES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.